Z169572442

Z169572442 is a novel small molecule identified as a potential allosteric activator of pyruvate kinase (PK), a crucial enzyme in the glycolytic pathway. Its activation is being explored as a therapeutic strategy to improve red blood cell metabolism and alleviate the severity of sickle cell disease (SCD). Discovered through a comprehensive computational approach involving molecular docking, density functional theory, molecular dynamics simulation, and ADMET predictions, Z169572442 demonstrated superior binding affinities and favorable pharmacokinetic properties compared to reference compounds like Mitapivat, suggesting its promise for further experimental validation in SCD treatment.